45 results on '"Ershova, Julia"'
Search Results
2. Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
3. Tuberculosis preventive treatment uptake among adults living with human immunodeficiency virus: Analysis of Zimbabwe population-based human immunodeficiency virus impact assessment 2020.
4. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021
5. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study
6. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
7. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance
8. Implementation of a methodological protocol for the national survey on tuberculosis catastrophic costs in Brazil
9. Comparison of sputum-culture conversion for Mycobacterium bovis and M. tuberculosis
10. The second national anti‐tuberculosis drug resistance survey in Tanzania, 2017–2018
11. Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
12. Mortality Among Tuberculosis Patients With Acquired Resistance to Second-line Antituberculosis Drugs—United States, 1993–2008
13. Epidemiology of primary multidrug-resistant tuberculosis, Vladimir Region, Russia
14. Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania
15. Acquired Resistance to Second-Line Drugs Among Persons With Tuberculosis in the United States
16. Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010
17. Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries
18. Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
19. Additional file 3 of Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
20. Additional file 1 of Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
21. Additional file 4 of Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
22. Additional file 5 of Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
23. Additional file 2 of Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania
24. Evaluation of community-based treatment for drug-resistant tuberculosis in Bangladesh
25. Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008–2010
26. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion
27. Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study
28. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned.
29. Comparison of Sputum-Culture Conversion forMycobacterium bovisandM. tuberculosis
30. The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey
31. Evaluation of community-based treatment for drug-resistant tuberculosis in Bangladesh
32. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance
33. Antituberculosis Drug Resistance Survey in Lesotho, 2008-2009: Lessons Learned
34. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies
35. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
36. Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
37. Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa
38. Weight Gain and Response to Treatment for Multidrug-Resistant Tuberculosis
39. Resistance to second-line drugs in multidrug-resistant tuberculosis – Authors' reply
40. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
41. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
42. High Levels Of Resistance To First And Second-Line Drugs Among MDR-TB Patients With Favourable Previous TB Treatment Outcomes In South Africa
43. Eastern Cape Province Has High Levels Of Resistance To Injectable Second-Line Drugs In Patients Starting Treatment For MDR-TB
44. HIV Infection In Patients With Multidrug-Resistant Tuberculosis From The Preserving Effective TB Treatment Study
45. Resistance to second-line drugs in rnultidrug resistant tuberculosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.